Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-15-027796
Filing Date
2015-09-29
Accepted
2015-09-29 14:59:39
Documents
2
Period of Report
2015-09-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1415
2 POWER OF ATTORNEY (PUBLIC): EXHIBIT 24 doc1.txt EX-24 3798
  Complete submission text file 0001127602-15-027796.txt   6593
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Patel Sanj K (Reporting) CIK: 0001532218 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 151130603